Two patients (P1 and P2) with deleterious variants in FIBCD1 exhibited symptoms of severe neurodevelopmental dysfunction, including delayed social, cognitive and verbal abilities, ASD, ADHD, facial dysmorphias, delayed sitting and walking milestones and structural brain anomalies. This evidence concerns the gene FIBCD1 and attention deficit-hyperactivity disorder.